XML 20 R10.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 4 - Employee Benefit Plans
6 Months Ended
Jun. 30, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
4.
EMPLOYEE BENEFIT PLANS
 
Nuvectra Corporation
2016
Equity Incentive Plan
– The Nuvectra Corporation
2016
Equity Incentive Plan (the
“2016
Equity Plan”) was initially adopted by the Board of Managers of QiG Group, LLC (the Company’s former name) and was subsequently ratified and approved by Nuvectra’s Board of Directors effective as of
March 14, 2016.
The
2016
Equity Plan provides that the Compensation and Organization Committee of the Board of Directors (the “Compensation Committee”)
may
award eligible participants, as it
may
determine from time to time, the following types of awards: stock options, stock appreciation rights, restricted stock, restricted stock units and stock bonuses. Subject to the adjustment clauses in the
2016
Equity Plan, the total number of shares of Nuvectra common stock reserved for issuance under the
2016
Equity Plan is
2,362,785.
 
During the
six
months ended
June 30, 2017,
the Compensation Committee granted equity awards aggregating
538,502
shares of common stock under the
2016
Equity Plan in the form of both restricted stock units and non-qualified stock options to its directors and certain officers and key employees. Compensation cost related to the
2016
Equity Plan for the
three
and
six
months ended
June 30, 2017
was approximately
$0.5
million and
$0.9
million, respectively.
 
During the
six
months ended
July 1, 2016,
the Compensation Committee granted equity awards aggregating
791,238
shares of common stock under the
2016
Equity Plan in the form of both restricted stock units and non-qualified stock options to its directors and certain officers and key employees. Compensation cost related to the
2016
Equity Plan for the
three
and
six
months ended
July 1, 2016
was approximately
$0.4
million and
$0.4
million, respectively.
 
Stock-Based Compensation
– Certain of the Company’s employees participated in the stock-based compensation programs of Integer and prior to the Spin-off received awards of time-based stock options and time- and performance-based restricted stock units, which typically vest over a
three
-year period and are settled in shares of Integer common stock. The stock-based payment compensation expense includes the compensation expense directly attributable to Nuvectra employees from these Integer equity incentives. In addition, certain incentive awards that were originally granted under an Integer equity incentive award plan adjusted into an incentive award of Nuvectra common stock at the time of the Spin-off. Compensation cost related to these Integer equity incentives was approximately
$0.1
million and
$0.2
million for the
three
and
six
months ended
June 30, 2017,
respectively. Compensation cost related to these Integer equity incentives was approximately
$0.1
million and
$0.8
million for the
three
and
six
months ended
July 1, 2016,
respectively.
 
 
The components and classification of stock-based compensation expense were as follows (in thousands):
 
 
 
Three Months Ended
 
 
Six Months Ended
 
 
 
June 30, 2017
 
 
July 1, 2016
 
 
June 30, 2017
 
 
July 1, 2016
 
Stock options
  $
239
    $
185
    $
410
    $
248
 
Restricted stock and restricted stock units
   
389
     
360
     
695
     
1,003
 
Total stock-based compensation expense
  $
628
    $
545
    $
1,105
    $
1,251
 
 
 
 
Three Months Ended
 
 
Six Months Ended
 
 
 
June 30, 2017
 
 
July 1, 2016
 
 
June 30, 2017
 
 
July 1, 2016
 
Selling, general and administrative expense
  $
542
    $
453
    $
984
    $
619
 
Research, development and engineering costs, net
   
86
     
92
     
121
     
163
 
Other operating expenses
   
     
     
     
469
 
Total stock-based compensation expense
  $
628
    $
545
    $
1,105
    $
1,251
 
 
The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model with weighted-average assumptions based on the grant date. The weighted average fair value and assumptions used to value options granted under the
2016
Equity Plan were as follows:
 
 
 
Three Months Ended
 
 
Six
Months Ended
 
                         
 
 
June 30, 2017
 
 
July 1, 2016
 
 
June 30, 2017
 
 
July 1, 2016
 
Weighted average fair value
  $
3.61
    $
4.50
    $
3.57
    $
4.50
 
Risk-free interest rate
   
2.04
%    
1.72
%    
2.06
%    
1.72
%
Expected volatility
   
55
%    
55
%    
55
%    
55
%
Holding period (in years)
   
6
     
10
     
6
     
10
 
Expected dividend yield
   
%    
%    
%    
%
 
 
The following table summarizes the stock option activity during the
first
six
months of fiscal year
2017:
 
 
 
Number of
Time-Vested
Stock
Options
 
 
Weighted
Average
Exercise
Price
 
 
Weighted
Average
Remaining
Contractual
Life (Years)
 
 
Aggregate
Intrinsic
Value
 
Outstanding at December 30, 2016
   
873,992
    $
6.49
     
 
     
 
 
Granted
   
332,469
     
6.74
     
 
     
 
 
Exercised
   
(16,007
)
   
4.91
     
 
     
 
 
Forfeited or expired
   
(28,880
)
   
7.79
     
 
     
 
 
Outstanding at June 30, 2017
   
1,161,574
    $
6.55
     
6.52
    $
7,813,773
 
Exercisable at June 30, 2017
   
616,615
    $
6.14
     
4.02
    $
4,399,729
 
  
The Company received proceeds totaling
$66,000
upon the exercise of
16,007
stock options during the
first
six
months of fiscal year
2017.
 
The following table summarizes the restricted stock and restricted stock unit activity during the
first
six
months of fiscal year
2017:
 
 
 
Time-Vested
Activity
 
 
Weighted
Average
Fair Value
 
Nonvested at December 30, 2016
   
551,224
    $
6.90
 
Granted
   
206,033
     
6.67
 
Vested
   
(146,754
)
   
6.47
 
Forfeited
   
(73,353
)
   
6.47
 
Nonvested at June 30, 2017
   
537,150
    $
6.86
 
 
Nuvectra Bonus Plan
– The terms of the Nuvectra Corporation Bonus Plan (the “Bonus Plan”) provides for both annual discretionary defined contribution cash bonuses and performance-based bonuses based upon Nuvectra’s company-wide performance measures and, for certain employees, individual performance measures that are set by Nuvectra’s executive management and, in some instances, members of the Board of Directors. Compensation cost related to the Bonus Plan for the
three
and
six
months ended
June 30, 2017
were approximately
$0.6
million and
$1.3
million, respectively. Compensation cost related to the Bonus Plan for the
three
and
six
months ended
July 1, 2016
were approximately
$0.3
million and
$1.0
million, respectively.
 
Defined Contribution Plans
– The Company sponsors a defined contribution
401
(k) plan for its employees. The plan provides for the deferral of employee compensation under Section
401
(k) of the Internal Revenue Code of
1986,
as amended (“Section
401
(k)”), and a discretionary match. For the
three
and
six
months ended
June 30, 2017
this match was
25%
per dollar of participant deferral, up to
6%
of the total compensation for each participant. Direct costs related to this defined contribution plan were
$0.07
million and
$0.1
million for the
three
and
six
months ended
June 30, 2017,
respectively.
 
Integer sponsors a defined contribution
401
(k) plan for its employees, in which the Company’s employees historically participated. The plan provides for the deferral of employee compensation under Section 
401
(k) and a discretionary match. Until the spin-off in the
first
quarter of fiscal year
2016
this match was
35%
 per dollar of participant deferral, up to
6%
of the total compensation for each participant. The
401
(k) compensation expense for the
first
quarter of fiscal year
2016
recognized in these
condensed consolidated financial statements includes all of the compensation expenses directly attributable to Nuvectra employees. Direct costs related to this defined contribution plan allocated to the Company were
$0.03
million and
$0.07
million for the
three
and
six
months ended
July 1, 2016,
respectively.